熱門資訊> 正文

Dyne Therapeutics股票发行价为350美元

2025-12-10 14:39

Dyne Therapeutics Inc(DYN) 0

Dyne Therapeutics (DYN) priced an upsized underwritten public offering of 18.98M shares at af $18.44 per share.
The gross proceeds are expected to be $350.0 million.
The offering is expected to close on or about December 11, 2025
The underwriters have a 30-day option to purchase up to an additional 2.85M shares.

More on Dyne Therapeutics

Dyne Therapeutics, Inc. (DYN) Discusses Positive Topline Results From DELIVER Registrational Expansion Cohort in Duchenne Muscular Dystrophy Transcript
Dyne Therapeutics, Inc. (DYN) Discusses Positive Topline Results From DELIVER Registrational Expansion Cohort in Duchenne Muscular Dystrophy - Slideshow
Dyne: Accelerated Approval Established Endpoint Sets Stage For DM1 Data In Mid-2026
Dyne Therapeutics announces $300M proposed public offering
Dyne, PepGen jump as potential beneficiaries of Novartis/Avidity deal

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。